Full Question & Answer Text (for Search Engines)
Question 1:
A 14-year-old male presents with left distal femoral pain and swelling. Imaging reveals a large metaphyseal lesion with cortical destruction and soft tissue extension. Biopsy confirms high-grade osteosarcoma. A whole-body PET-CT scan shows no distant metastases but highlights a separate, small, enhancing lesion within the same femur, proximal to the primary tumor. According to the 8th edition UICC staging criteria for bone sarcomas, what is the correct T-stage for this patient's primary tumor?
Options:
Correct Answer: T3
Explanation:
For bone sarcomas (like osteosarcoma), the 8th edition UICC T-staging system is as follows: T1 is for tumors ≤ 8 cm, T2 for tumors > 8 cm. T3 is specifically designated for discontinuous tumor foci in the primary bone, commonly known as 'skip lesions.' The description of a separate, enhancing lesion within the same femur proximal to the primary tumor perfectly fits the definition of a skip lesion, regardless of the primary tumor's size. Therefore, the T-stage is T3.
Question 2:
A 65-year-old male presents with a progressively enlarging, painless mass in his right thigh for 6 months. MRI reveals a 12 cm deep-seated, heterogeneous mass. Biopsy confirms high-grade pleomorphic undifferentiated sarcoma (PUS). Imaging of the chest, abdomen, and pelvis is negative for metastases, and lymph nodes are unremarkable. What is the correct UICC T-stage for this soft tissue sarcoma of the extremity?
Options:
Correct Answer: T3
Explanation:
For soft tissue sarcomas of the trunk and extremities, the 8th edition UICC T-staging is based primarily on tumor size: T1 for tumors ≤ 5 cm, T2 for tumors > 5 cm and ≤ 10 cm, and T3 for tumors > 10 cm. The described tumor is 12 cm, which places it in the T3 category. T4 is reserved for tumors of any size with invasion of major neurovascular structures, bone, joint, or visceral organs. Since invasion of these critical structures is not mentioned, T3 is the correct stage based on size alone.
Question 3:
In the context of the UICC staging system for musculoskeletal sarcomas, which factor is *not* a primary determinant of the Grade (G) component?
Options:
- Tumor cellularity
- Mitotic activity
- Extent of necrosis
- Pleomorphism
- Tumor size
Correct Answer: Tumor size
Explanation:
The Grade (G) component in the UICC staging system for musculoskeletal sarcomas, particularly for soft tissue sarcomas (often using the FNCLCC system), is determined by histopathological features such as tumor differentiation, mitotic activity, and the extent of tumor necrosis. Pleomorphism and cellularity are aspects of differentiation. Tumor size, however, is a primary determinant of the T-stage (primary tumor extent), not the G-stage (histological grade). Therefore, tumor size is not a primary determinant of the Grade component.
Question 4:
A 28-year-old female is diagnosed with a high-grade synovial sarcoma in her left forearm. Staging workup reveals a single, isolated pulmonary nodule consistent with metastatic disease. There is no regional lymph node involvement. According to the 8th edition UICC staging for soft tissue sarcomas, what is the overall stage group?
Options:
- Stage IIB
- Stage III
- Stage IVA
- Stage IVB
- Stage IA
Correct Answer: Stage IVB
Explanation:
The presence of distant metastases (M1) automatically upstages any sarcoma to Stage IV. For soft tissue sarcomas in the 8th edition UICC, M1 disease is classified as Stage IVA if there are no regional lymph node metastases (N0). If regional lymph node metastases (N1) are present alongside distant metastases, it would be Stage IVB. In this case, with M1 and N0, the overall stage is IVA.
Question 5:
Which of the following describes the M1a designation for bone sarcomas in the 8th edition UICC staging system?
Options:
- Distant metastasis to lung only
- Distant metastasis to bone only
- Distant metastasis to other sites (e.g., liver)
- Regional lymph node metastasis
- Peritoneal metastasis
Correct Answer: Distant metastasis to lung only
Explanation:
In the 8th edition UICC staging system for bone sarcomas (e.g., osteosarcoma, Ewing sarcoma), M1a specifically refers to distant metastasis to the lung only. M1b refers to distant metastasis to bone or other distant sites (e.g., liver, brain). This distinction can be important prognostically, as isolated lung metastases sometimes have a better prognosis and are amenable to surgical resection in select cases.
Question 6:
A 55-year-old male with a history of prostate cancer develops a blastic lesion in his thoracic spine causing cord compression. Which of the following is the *most appropriate* initial treatment strategy for his spinal cord compression, assuming good functional status otherwise?
Options:
- Systemic chemotherapy
- External beam radiation therapy
- Surgical decompression and stabilization
- Bisphosphonates and observation
- Radiofrequency ablation
Correct Answer: Surgical decompression and stabilization
Explanation:
For metastatic spinal cord compression, especially with neurological compromise (even early), surgical decompression and stabilization is often the most appropriate and rapid initial treatment, particularly for patients with good functional status and reasonable life expectancy. It provides immediate relief of compression and allows for stabilization of the spine, preventing further neurological deterioration. While radiation therapy is crucial, it often follows surgery or is used alone in patients who are not surgical candidates or have radiosensitive tumors without significant instability. Systemic chemotherapy addresses the underlying cancer but is usually not fast enough to relieve acute cord compression. Bisphosphonates are for bone strengthening and pain, not acute compression. RFA is for local tumor control, not broad decompression.
Question 7:
Regarding chondrosarcoma, which of the following statements about its staging and prognosis is most accurate?
Options:
- High-grade chondrosarcomas (G3) typically respond well to neoadjuvant chemotherapy.
- The T-stage for appendicular chondrosarcoma is solely based on tumor size in the 8th edition UICC.
- Enneking surgical staging is more commonly used than UICC for central chondrosarcomas.
- The primary prognostic factor for chondrosarcoma is the presence of skip lesions.
- Malignant transformation of an osteochondroma is generally considered a G1 chondrosarcoma.
Correct Answer: The T-stage for appendicular chondrosarcoma is solely based on tumor size in the 8th edition UICC.
Explanation:
For bone sarcomas, including chondrosarcoma, the 8th edition UICC T-stage is primarily based on tumor size (T1 ≤ 8cm, T2 > 8cm) or the presence of skip lesions (T3). Unlike other bone sarcomas, chondrosarcomas are generally considered chemo- and radio-resistant, so neoadjuvant chemotherapy is not a standard effective treatment for high-grade lesions. Enneking staging is a surgical staging system, important for surgical planning, but UICC is the primary prognostic staging system. While skip lesions (T3) are a factor in T-staging, the histological grade (G) is generally considered the most significant prognostic factor for chondrosarcoma, directly correlating with metastatic potential. Malignant transformation of an osteochondroma typically results in a secondary peripheral chondrosarcoma, often low-grade (G1 or G2), not universally G1 and not a distinct type of primary chondrosarcoma within the staging system.
Question 8:
Which of the following imaging modalities is considered the gold standard for assessing the local extent and relationship of a primary soft tissue sarcoma to neurovascular structures, critical for surgical planning?
Options:
- X-ray
- CT scan with contrast
- Bone scan
- MRI with contrast
- PET-CT scan
Correct Answer: MRI with contrast
Explanation:
MRI with contrast is considered the gold standard for evaluating the local extent of a soft tissue sarcoma. It provides superior soft tissue resolution compared to CT and is excellent for delineating the tumor's margins, its relationship to critical neurovascular bundles, muscle compartments, and bone, which are all crucial for planning wide surgical excision and determining the feasibility of limb salvage. While CT is useful for bone involvement and chest staging, and PET-CT for metabolic activity and distant metastases, MRI offers the best local anatomical detail for surgical planning.
Question 9:
A 70-year-old male with a history of chronic alcoholism and liver cirrhosis develops a painful, enlarging mass in his proximal humerus. Biopsy reveals epithelioid hemangioendothelioma. Staging shows no regional lymph node or distant metastases. Given the primary tumor's aggressive local growth potential, what is the typical surgical margin required for definitive treatment of this primary bone tumor?
Options:
- Intralesional
- Marginal
- Wide
- Radical
- Contaminated
Correct Answer: Wide
Explanation:
Epithelioid hemangioendothelioma, despite its often low-grade histological appearance, can behave aggressively with a tendency for local recurrence and multifocal presentation. For definitive treatment of primary bone tumors considered malignant or with significant aggressive potential, a 'wide' surgical margin is generally required. A wide margin involves removing the tumor en bloc with a cuff of healthy normal tissue completely surrounding the lesion. Marginal excision risks local recurrence for such lesions. Intralesional is for benign tumors or palliative care. Radical excision involves removal of an entire anatomical compartment (e.g., amputation), which may be necessary in extreme cases but is not the general requirement for all malignant bone tumors if wide excision is achievable. Contaminated margins are not a goal.
Question 10:
In the Enneking surgical staging system for musculoskeletal sarcomas, which of the following is characteristic of Stage IIB?
Options:
- Low-grade, intra-compartmental, no metastases
- Low-grade, extra-compartmental, no metastases
- High-grade, intra-compartmental, no metastases
- High-grade, extra-compartmental, no metastases
- Any grade, any compartmental, with regional metastases
Correct Answer: High-grade, extra-compartmental, no metastases
Explanation:
The Enneking surgical staging system classifies musculoskeletal sarcomas based on Grade (G), Location (T), and Metastasis (M). Grade is either Low (G0) or High (G1). Location is either Intra-compartmental (T0) or Extra-compartmental (T1). Metastasis is either None (M0) or Present (M1). Stage II corresponds to high-grade lesions (G1). Stage IIA is high-grade, intra-compartmental (G1T0M0). Stage IIB is high-grade, extra-compartmental (G1T1M0). Stage III involves any grade with metastasis (M1). Therefore, IIB is High-grade, extra-compartmental, with no regional or distant metastases.
Question 11:
A 10-year-old female presents with severe pain and swelling in her right tibia. Biopsy confirms Ewing sarcoma. Staging studies reveal extensive metastatic disease to the lungs and multiple bones. What is the most critical prognostic factor for this patient, beyond the primary tumor characteristics?
Options:
- Patient age
- Tumor size
- Location of primary tumor
- Presence and extent of metastatic disease
- Response to neoadjuvant chemotherapy
Correct Answer: Presence and extent of metastatic disease
Explanation:
For Ewing sarcoma, as with most aggressive sarcomas, the presence and extent of metastatic disease at presentation is the single most critical prognostic factor. Patients with localized disease have significantly better survival rates than those with metastatic disease. While age, tumor size, and location are also important prognostic indicators for localized disease, the presence of widespread metastases fundamentally alters the prognosis. Response to neoadjuvant chemotherapy is crucial for localized disease but is not a primary factor *at presentation* when metastases are already identified.
Question 12:
Which of the following is generally considered a contraindication to limb-salvage surgery for a primary high-grade bone sarcoma of the extremity?
Options:
- Pathological fracture through the tumor
- Pediatric patient with open physes
- Proximity to a major nerve
- Extensive neurovascular bundle involvement not amenable to reconstruction
- Large tumor size (>10 cm)
Correct Answer: Extensive neurovascular bundle involvement not amenable to reconstruction
Explanation:
Extensive involvement of the neurovascular bundle that precludes a wide margin resection without sacrificing critical neurovascular structures, and where reconstruction is not feasible or would result in a non-functional limb, is generally a contraindication to limb-salvage surgery. In such cases, amputation may be necessary to achieve oncologic clearance and a functional outcome. While a pathological fracture can complicate limb salvage, it is not an absolute contraindication if soft tissue contamination can be managed. Open physes in children require careful consideration but do not contraindicate limb salvage (often addressed with expandable prostheses or growth-sparing techniques). Proximity to a major nerve can be challenging but is often managed with meticulous dissection or nerve grafting if necessary, not an absolute contraindication. Large tumor size makes limb salvage more difficult but is not an absolute contraindication if oncologic margins and functional outcomes can be achieved.
Question 13:
A 45-year-old male undergoes wide local excision for a 6 cm high-grade myxofibrosarcoma of the forearm. Pathological review reveals tumor at the deep margin (R1 resection). What is the most appropriate next step in management?
Options:
- Observation with close follow-up
- Systemic chemotherapy
- Adjuvant radiation therapy to the tumor bed
- Repeat wide local excision
- Amputation of the forearm
Correct Answer: Repeat wide local excision
Explanation:
For soft tissue sarcomas, a positive surgical margin (R1: microscopic tumor at margin; R2: macroscopic tumor at margin) is a strong predictor of local recurrence. The primary goal is to achieve negative margins (R0). Therefore, the most appropriate next step after an R1 resection of a high-grade soft tissue sarcoma is typically a re-excision to obtain clear margins, if technically feasible without unacceptable morbidity. If re-excision is not possible or carries significant risk, then adjuvant radiation therapy may be considered, but re-excision is generally preferred for achieving local control. Chemotherapy is not typically indicated for local control of R1 resections. Amputation is usually reserved for unresectable tumors or recurrent disease after multiple attempts at limb salvage.
Question 14:
Which histological subtype of primary bone sarcoma is most commonly associated with a preceding history of Paget's disease of bone?
Options:
- Osteosarcoma
- Chondrosarcoma
- Ewing sarcoma
- Fibrosarcoma
- Giant cell tumor of bone
Correct Answer: Osteosarcoma
Explanation:
Osteosarcoma is the most common primary malignant bone tumor to arise in bone affected by Paget's disease (Paget's sarcoma). These are typically high-grade, aggressive osteosarcomas occurring in older patients, often presenting in the femur, pelvis, or humerus. While other sarcomas can rarely occur, osteosarcoma is by far the most recognized association.
Question 15:
A patient with osteosarcoma of the proximal tibia has an excellent response to neoadjuvant chemotherapy, with >90% tumor necrosis on post-chemotherapy pathological examination of the resected specimen. How does this finding correlate with prognosis?
Options:
- It indicates a poor prognosis due to rapid tumor turnover.
- It is a strong positive prognostic factor, associated with improved survival.
- It has no significant correlation with overall prognosis.
- It suggests a high likelihood of distant metastatic recurrence.
- It primarily impacts the choice of adjuvant radiation therapy.
Correct Answer: It is a strong positive prognostic factor, associated with improved survival.
Explanation:
For osteosarcoma, the degree of tumor necrosis after neoadjuvant chemotherapy is a critical prognostic factor. Patients who achieve >90% tumor necrosis (a 'good responder') have significantly better long-term survival rates compared to those with <90% necrosis ('poor responders'). This robust pathological response indicates the efficacy of systemic treatment against micrometastatic disease and is strongly associated with improved prognosis. It does not indicate poor prognosis or high likelihood of distant recurrence; quite the opposite.
Question 16:
In the UICC staging of giant cell tumor of bone (GCTB), what is the significance of pulmonary metastases?
Options:
- They automatically classify the GCTB as malignant (sarcoma).
- They signify a poor prognosis, similar to other aggressive sarcomas.
- They are considered rare and usually associated with very aggressive primary tumors.
- They are classified as M1 disease but often have a relatively indolent course, sometimes amenable to surgery.
- They are not included in the UICC staging for GCTB, as GCTB is considered benign.
Correct Answer: They are classified as M1 disease but often have a relatively indolent course, sometimes amenable to surgery.
Explanation:
Giant cell tumor of bone (GCTB) is an unusual bone tumor that, while histologically benign, has local aggressive potential and a small but definite risk of pulmonary metastases (3-5%). These pulmonary metastases, even though classified as M1 disease, often have a more indolent course than metastases from conventional high-grade sarcomas. They are often multiple, small, and can remain stable for long periods. They are amenable to surgical resection in many cases, and their presence does not necessarily imply a rapidly fatal outcome or malignant transformation, though they do indicate a more aggressive biological behavior than localized GCTB. They are indeed included in the UICC staging (M1).
Question 17:
Which of the following describes the preferred surgical approach for a low-grade (G1) appendicular chondrosarcoma with an intact cortical shell and no extra-osseous extension?
Options:
- Intralesional curettage
- Marginal excision
- Wide en bloc resection
- Amputation
- Radiation therapy alone
Correct Answer: Marginal excision
Explanation:
For low-grade (G1) chondrosarcomas that are intra-osseous and do not have significant cortical destruction or soft tissue extension, a marginal excision is often considered appropriate. This involves removing the tumor with a narrow margin of normal tissue surrounding it. While intralesional curettage can be considered for very low-grade, well-contained lesions in specific anatomical sites, marginal excision offers better local control for G1 chondrosarcomas. Wide en bloc resection is generally reserved for higher-grade lesions or those with extra-osseous extension. Amputation is typically for extensive, unresectable, or recurrent disease.
Question 18:
A 15-year-old female with a known osteosarcoma of the distal femur undergoes a chest CT as part of her staging workup. The CT reveals a 3 mm indeterminate pulmonary nodule. What is the most appropriate next step in management?
Options:
- Proceed with neoadjuvant chemotherapy as planned and re-evaluate the nodule after treatment.
- Perform an immediate biopsy of the pulmonary nodule.
- Discontinue neoadjuvant chemotherapy and initiate palliative care.
- Repeat chest CT in 3 months to monitor the nodule's growth.
- Perform a PET-CT to further characterize the nodule.
Correct Answer: Proceed with neoadjuvant chemotherapy as planned and re-evaluate the nodule after treatment.
Explanation:
Small, indeterminate pulmonary nodules (especially <5 mm) are common, and many are benign. For osteosarcoma, neoadjuvant chemotherapy is a critical part of the treatment regimen. It is standard practice to proceed with chemotherapy as planned. The nodules are then re-evaluated after chemotherapy; many will either disappear, remain stable (suggesting benignity), or grow (suggesting malignancy and requiring further intervention like resection). Immediate biopsy of such small nodules is often non-diagnostic and carries risks. Discontinuing chemotherapy and starting palliative care would be premature and inappropriate. Monitoring with repeat CT is often done, but typically after the initial chemotherapy phase for osteosarcoma, as the primary goal is to treat the known disease effectively.
Question 19:
Which feature of a soft tissue mass on MRI is most indicative of malignancy and would warrant immediate biopsy?
Options:
- Homogeneous signal intensity
- Well-defined capsule
- Infiltration into adjacent structures
- Absence of contrast enhancement
- Location in the subcutaneous fat
Correct Answer: Infiltration into adjacent structures
Explanation:
Infiltration into adjacent structures (muscle, fascia, neurovascular bundles, or bone) is a strong indicator of malignancy in a soft tissue mass. Malignant tumors tend to have infiltrative growth patterns. Homogeneous signal intensity and a well-defined capsule are more characteristic of benign lesions. Malignant tumors typically show heterogeneous signal intensity and often lack a well-defined capsule. Absence of contrast enhancement is usually seen in benign lesions (e.g., simple cysts, some lipomas), whereas most malignant soft tissue tumors enhance. While subcutaneous fat location can harbor sarcomas, deep-seated lesions are generally at higher risk of malignancy, and location alone isn't as indicative as infiltrative growth.
Question 20:
What is the primary reason why 'Frozen Section Biopsy' is generally discouraged as the definitive diagnostic tool for suspected soft tissue or bone sarcomas?
Options:
- It requires specialized equipment not available in most hospitals.
- It has a high false-negative rate for low-grade tumors.
- Accurate grading and subtyping, crucial for planning, are often not possible.
- It significantly increases the risk of tumor dissemination.
- It is more painful for the patient than needle biopsy.
Correct Answer: Accurate grading and subtyping, crucial for planning, are often not possible.
Explanation:
Frozen section biopsy is primarily used for rapid intraoperative assessment (e.g., checking margins), but it is generally insufficient for the definitive diagnosis of sarcomas. The complexity and heterogeneity of sarcomas mean that accurate grading and subtyping, which are crucial for treatment planning (e.g., choice of chemotherapy, surgical approach), often require extensive immunohistochemical staining and sometimes molecular studies that cannot be performed on frozen sections. A high false-negative rate for low-grade tumors is a concern, but the main issue is the inability to get precise characterization. It doesn't inherently increase dissemination risk more than other biopsies if performed correctly, and pain levels are comparable to other surgical biopsies.
Question 21:
A 5-year-old child presents with a femoral shaft lesion and constitutional symptoms. Biopsy confirms Ewing sarcoma. What is the most common site of distant metastasis at presentation for Ewing sarcoma?
Options:
- Brain
- Liver
- Lymph nodes
- Lungs and other bones
- Kidneys
Correct Answer: Lungs and other bones
Explanation:
Ewing sarcoma is highly aggressive and commonly presents with metastatic disease. The most common sites of distant metastasis at presentation are the lungs (pulmonary metastases) and other bones (skeletal metastases). Bone marrow involvement is also frequent. While other sites can be involved, lungs and other bones are the predominant sites. Lymph node involvement is less common than for carcinomas but can occur. Brain, liver, and kidneys are less frequent primary metastatic sites at presentation.
Question 22:
Which of the following is considered the primary 'oncological' function of neoadjuvant (preoperative) chemotherapy in the treatment of high-grade osteosarcoma?
Options:
- To reduce the size of the tumor to facilitate limb-salvage surgery.
- To evaluate the tumor's sensitivity to chemotherapy for postoperative regimen adjustment.
- To treat micrometastatic disease not detectable by conventional imaging.
- To alleviate pain and improve functional status prior to surgery.
- To sterilize the tumor margins to prevent local recurrence.
Correct Answer: To treat micrometastatic disease not detectable by conventional imaging.
Explanation:
While neoadjuvant chemotherapy can reduce tumor size (facilitating limb salvage) and alleviate pain, its primary oncological function in high-grade osteosarcoma is to treat micrometastatic disease that is presumed to be present at diagnosis, even if not detectable on imaging. Osteosarcoma has a high propensity for early systemic spread. Preoperative chemotherapy aims to eradicate these micrometastases, thereby improving overall survival. Evaluating tumor sensitivity (pathological response) is a crucial secondary benefit, as it guides adjuvant therapy. Sterilizing tumor margins is an indirect benefit if the tumor shrinks, but achieving clear surgical margins remains paramount, and chemotherapy doesn't guarantee margin sterility.
Question 23:
A 30-year-old patient undergoes surgical resection of a low-grade chondrosarcoma from the proximal humerus. The surgeon achieves an intralesional margin due to anatomical constraints (proximity to glenoid and neurovascular structures) but meticulously burrs the cavity and uses adjuvant cryotherapy. What is the most significant risk associated with this approach for a chondrosarcoma?
Options:
- Increased risk of pathological fracture
- High rate of distant metastasis
- Significant increase in local recurrence
- Development of post-operative infection
- Compromised shoulder function
Correct Answer: Significant increase in local recurrence
Explanation:
Chondrosarcomas, even low-grade ones, are known for their potential for local recurrence, especially after intralesional or marginal resections. Chondrosarcoma cells can be left behind within the pseudo-capsule or surrounding tissues with intralesional approaches. While adjuvant treatments like burring and cryotherapy aim to reduce this risk, an intralesional margin inherently carries a significantly higher risk of local recurrence compared to marginal or wide excisions. Pathological fracture, distant metastasis (for low-grade, this risk is low), infection, and functional compromise are potential complications of any surgery but not the *most significant* risk specific to an intralesional approach for chondrosarcoma. Local recurrence is the primary concern for oncologic outcome.
Question 24:
In the context of the 8th edition UICC staging for soft tissue sarcomas, which characteristic automatically upgrades the T-stage to T4, irrespective of tumor size?
Options:
- Tumor depth (superficial vs. deep)
- Tumor location (trunk vs. extremity)
- Invasion of major neurovascular structures
- High histological grade (G3)
- Presence of regional lymph node metastases
Correct Answer: Invasion of major neurovascular structures
Explanation:
For soft tissue sarcomas of the trunk and extremities (8th edition UICC), T4 is defined as a tumor of any size that invades a major neurovascular structure, bone, joint, or visceral organs. This is a critical distinction that reflects the increased complexity and morbidity of resection, and often poorer prognosis. Tumor depth (superficial vs. deep) used to be a T-stage modifier but is now primarily a prognostic factor. Tumor location doesn't change the T-stage definition but might influence overall prognosis. High histological grade is the G-stage. Regional lymph node metastases are part of the N-stage.
Question 25:
Which of the following bone tumors is characteristically pain-responsive to NSAIDs and often appears as a small, lucent nidus with surrounding dense sclerosis on X-ray?
Options:
- Osteosarcoma
- Ewing sarcoma
- Osteoid osteoma
- Enchondroma
- Non-ossifying fibroma
Correct Answer: Osteoid osteoma
Explanation:
Osteoid osteoma is a benign bone-forming tumor characterized by nocturnal pain that is classically relieved by NSAIDs (like aspirin). Radiographically, it presents as a small lucent nidus (typically <1.5-2 cm) surrounded by a zone of reactive sclerosis. This classic presentation makes it distinct from the other options, which either do not have this pain response (Enchondroma, Non-ossifying fibroma) or have very different radiographic appearances and clinical presentations (Osteosarcoma, Ewing Sarcoma).
Question 26:
For patients with primary bone sarcoma, which of the following is the most significant factor influencing the prognosis of those with *localized* disease?
Options:
- Patient's age at diagnosis
- Tumor size
- Primary tumor location (axial vs. appendicular)
- Response to neoadjuvant chemotherapy (pathologic necrosis)
- Histological subtype
Correct Answer: Response to neoadjuvant chemotherapy (pathologic necrosis)
Explanation:
While patient's age, tumor size, location, and histological subtype all have prognostic significance for localized bone sarcomas, the response to neoadjuvant chemotherapy, as measured by the percentage of tumor necrosis in the resected specimen, is consistently one of the most powerful and independent prognostic factors. A 'good response' (typically >90-95% necrosis) is strongly associated with improved event-free and overall survival. This is a key 'Nevin Insight' into evaluating the efficacy of systemic therapy. The other factors are important, but chemotherapy response integrates the biological aggressiveness of the tumor with the effectiveness of treatment.
Question 27:
A 60-year-old male presents with a painful mass in his sacrum. Biopsy reveals chordoma. What is the most common site of distant metastasis for chordoma?
Options:
- Lung
- Liver
- Brain
- Regional lymph nodes
- Bone
Correct Answer: Lung
Explanation:
Chordoma is a rare, slow-growing, malignant bone tumor derived from notochordal remnants, most commonly found in the sacrococcygeal region and skull base. While it is characterized by local aggressiveness and high rates of local recurrence, distant metastases do occur, with the lung being the most common site. Bone and soft tissue metastases also occur but are less frequent than lung metastases. Liver and brain metastases are relatively rare.
Question 28:
Which of the following pathological findings is most suggestive of an aggressive, high-grade soft tissue sarcoma?
Options:
- Scattered mitotic figures, no necrosis
- Uniform cells, bland nuclei, minimal pleomorphism
- Extensive cellular pleomorphism, numerous atypical mitotic figures, geographic necrosis
- Presence of fatty differentiation, well-defined septae
- Sclerotic stroma, low cellularity
Correct Answer: Extensive cellular pleomorphism, numerous atypical mitotic figures, geographic necrosis
Explanation:
The combination of extensive cellular pleomorphism (variation in cell size and shape), numerous atypical mitotic figures (indicating rapid and uncontrolled cell division), and geographic necrosis (areas of dead tumor cells, often extensive) are hallmark features of high-grade, aggressive soft tissue sarcomas. These features are key components in grading systems like FNCLCC. The other options describe features more typical of low-grade sarcomas or benign lesions.
Question 29:
For a patient diagnosed with a Stage IIB (UICC 8th ed.) osteosarcoma of the proximal tibia, which M-stage (metastasis) is implicitly assumed?
Options:
Correct Answer: M0
Explanation:
In the 8th edition UICC staging for bone sarcomas, Stage IIB refers to a high-grade (G3 or G2 if applicable by context, typically G3 for osteosarcoma) tumor with T2 (tumor >8 cm) or T3 (skip lesions) but *without* any regional lymph node involvement (N0) or distant metastasis (M0). The presence of any metastasis (M1) would automatically upgrade the stage to Stage IV. Therefore, for Stage IIB, M0 is implicitly assumed.
Question 30:
A 12-year-old male with a distal femoral Ewing sarcoma undergoes neoadjuvant chemotherapy. After 3 cycles, MRI shows significant tumor shrinkage and sclerotic changes within the tumor. What is the most appropriate interpretation of these imaging findings?
Options:
- The tumor is progressing despite chemotherapy.
- The patient is a poor responder to chemotherapy, requiring a change in regimen.
- These findings are suggestive of a good response to chemotherapy.
- The tumor is likely benign and does not require further treatment.
- The patient should proceed directly to amputation.
Correct Answer: These findings are suggestive of a good response to chemotherapy.
Explanation:
Significant tumor shrinkage (reduction in size) and sclerotic changes (increased bone density) within a bone sarcoma after neoadjuvant chemotherapy are strong indicators of a good response to treatment. These changes represent tumor cell kill and replacement by osteoid/fibrotic tissue. This often correlates with a good pathological response (high percentage of necrosis). Tumor progression would involve growth or new lesions. A poor response would show minimal change or continued growth. Proceeding directly to amputation or assuming benignity would be incorrect based on these positive findings.
Question 31:
Which of the following is considered the primary role of a positron emission tomography (PET) scan in the staging of musculoskeletal sarcomas?
Options:
- Assessing local tumor extent and invasion of neurovascular structures.
- Identifying skip lesions within the primary bone.
- Detecting distant metastases and occult disease, particularly in lymph nodes or bone.
- Evaluating tumor response to neoadjuvant chemotherapy.
- Differentiating between benign and malignant bone lesions.
Correct Answer: Detecting distant metastases and occult disease, particularly in lymph nodes or bone.
Explanation:
The primary role of PET-CT in the staging of musculoskeletal sarcomas is to detect distant metastases and occult disease, particularly in regional lymph nodes or other bones, and sometimes in lung/liver, especially when conventional imaging is equivocal. Sarcomas are often metabolically active, making PET-CT sensitive for metastatic disease. MRI is superior for local extent and neurovascular involvement. Skip lesions are primarily detected by MRI. While PET-CT can sometimes help evaluate response, pathological necrosis is the gold standard. Differentiating benign from malignant is primarily done by biopsy, though PET can aid in identifying suspicious lesions.
Question 32:
A 40-year-old male presents with a suspected Grade 2 chondrosarcoma of the proximal femur. After biopsy confirms the diagnosis, what is the generally accepted surgical principle for this type of tumor?
Options:
- Intralesional curettage with adjuvant cryotherapy.
- Marginal excision.
- Wide en bloc resection.
- Amputation due to high recurrence risk.
- Radiation therapy as primary treatment.
Correct Answer: Wide en bloc resection.
Explanation:
Grade 2 chondrosarcomas have a higher metastatic potential and local recurrence risk than Grade 1 lesions. Therefore, the generally accepted surgical principle for a Grade 2 chondrosarcoma is a wide en bloc resection, aiming for negative microscopic margins. Marginal excision may be acceptable for very select low-grade (G1) lesions, but for G2, a wide margin is necessary for optimal local control. Intralesional approaches are associated with unacceptably high local recurrence rates for G2. Amputation is reserved for extensive, unresectable, or recurrent disease. Chondrosarcomas are generally radioresistant, so radiation therapy is typically used as an adjuvant for positive margins or inoperable disease, not as primary treatment.
Question 33:
Which of the following soft tissue sarcomas is characterized by a reciprocal translocation t(X;18)(p11.2;q11.2) and often presents in adolescents and young adults, typically in the extremities?
Options:
- Liposarcoma
- Myxofibrosarcoma
- Pleomorphic undifferentiated sarcoma
- Synovial sarcoma
- Dermatofibrosarcoma protuberans
Correct Answer: Synovial sarcoma
Explanation:
Synovial sarcoma is genetically characterized by the specific and recurrent reciprocal translocation t(X;18)(p11.2;q11.2), which results in the fusion gene SS18-SSX. This is a highly characteristic molecular signature and is often used diagnostically. It typically affects adolescents and young adults, most commonly occurring near large joints of the extremities, especially the knee. The other sarcomas listed do not share this specific translocation.
Question 34:
In the management of osteosarcoma, what is the primary purpose of obtaining a 'surgical margin' and how is it defined?
Options:
- To assess tumor grade; defined by the degree of tumor necrosis.
- To predict chemotherapy response; defined by tumor shrinkage.
- To achieve local tumor control; defined by the microscopic distance between the tumor and the cut edge of the resected specimen.
- To determine metastatic potential; defined by lymph node involvement.
- To select the type of limb reconstruction; defined by bone involvement.
Correct Answer: To achieve local tumor control; defined by the microscopic distance between the tumor and the cut edge of the resected specimen.
Explanation:
The primary purpose of obtaining a 'surgical margin' in osteosarcoma (and other sarcomas) is to achieve local tumor control. It is defined by the microscopic distance (or lack thereof) between the tumor cells and the cut edge of the resected surgical specimen. A 'wide' or 'negative' margin (R0 resection) means no tumor cells are seen at the cut edge, which significantly reduces the risk of local recurrence. This is distinct from tumor grade, chemotherapy response, metastatic potential, or reconstruction choice, although all are interrelated aspects of oncology.
Question 35:
Which statement regarding the staging of osteosarcoma in children is most accurate?
Options:
- The depth of invasion into adjacent soft tissue is a primary T-stage criterion.
- Regional lymph node metastases are rare but, when present, significantly worsen prognosis.
- Routine lymphadenectomy is indicated for all high-grade osteosarcomas.
- UICC staging considers tumor size and skip lesions, but not grade for initial stage grouping.
- Metastatic disease to the lungs is generally treated with palliative care only.
Correct Answer: Regional lymph node metastases are rare but, when present, significantly worsen prognosis.
Explanation:
For osteosarcoma, regional lymph node metastases are indeed rare (<5%) but, when present (N1 disease), they are a strong indicator of aggressive disease and significantly worsen prognosis, similar to distant metastases. They automatically upstage the disease to Stage III (UICC 8th ed.) if N1M0, or Stage IVB if N1M1. Routine lymphadenectomy is not indicated due to the rarity of involvement and lack of proven survival benefit. The T-stage for bone sarcomas is based on size and skip lesions, not depth of soft tissue invasion for T-staging itself. Grade is incorporated into overall stage grouping (G3 is higher stage). Metastatic lung disease in osteosarcoma is often aggressively managed with surgical resection (metastasectomy) in conjunction with chemotherapy, as it can be curative in select patients, not just palliative.
Question 36:
A 70-year-old male with a history of recurrent basal cell carcinoma presents with a rapidly growing, painful lesion on his left shoulder. Biopsy shows high-grade undifferentiated pleomorphic sarcoma. Staging reveals no distant metastases but enlarged, metabolically active left axillary lymph nodes. According to the 8th edition UICC for soft tissue sarcoma, what is the N-stage for this patient?
Options:
Correct Answer: N1
Explanation:
For soft tissue sarcomas in the 8th edition UICC, N1 designates regional lymph node metastasis. N0 means no regional lymph node metastasis. The presence of enlarged, metabolically active lymph nodes consistent with metastasis would classify the patient as N1. This finding significantly impacts the overall stage group, typically advancing it to Stage III or IVB depending on the M-stage.
Question 37:
Which benign bone tumor is most commonly found in the metaphysis of long bones, particularly the distal femur or proximal tibia, and has a characteristic 'ground glass' or 'fibrous' appearance on X-ray, often with an intact cortex?
Options:
- Osteochondroma
- Non-ossifying fibroma (NOF)
- Fibrous dysplasia
- Enchondroma
- Osteoblastoma
Correct Answer: Fibrous dysplasia
Explanation:
Fibrous dysplasia is a developmental anomaly of bone characterized by the replacement of normal bone marrow and cancellous bone with fibrous tissue and immature woven bone. It classically presents in the metaphysis/diaphysis of long bones (e.g., femur, tibia), has a 'ground glass' or 'shepherd's crook' deformity appearance on X-ray, often with an intact or expanded cortex. Non-ossifying fibroma is also metaphyseal but has a more 'bubbly' or 'soap-bubble' appearance. Osteochondroma is an exostosis. Enchondroma is a cartilaginous lesion, often in small bones of hands/feet. Osteoblastoma is similar to osteoid osteoma but larger.
Question 38:
A patient is undergoing evaluation for a suspected low-grade chondrosarcoma of the ilium. Which of the following diagnostic imaging techniques is most crucial for defining the intra-pelvic extent of the tumor and its relationship to major vessels and nerves?
Options:
- Plain radiographs
- Bone scintigraphy
- CT scan with intravenous contrast
- MRI with intravenous contrast
- PET-CT scan
Correct Answer: MRI with intravenous contrast
Explanation:
For pelvic bone tumors, especially those involving complex anatomical structures like major vessels and nerves, MRI with intravenous contrast is the most crucial imaging modality. It provides superior soft tissue contrast and multiplanar capabilities, allowing for precise delineation of tumor extent, marrow involvement, and its relationship to critical neurovascular structures within the pelvis. While CT is excellent for bony detail and calcification, and PET-CT for metabolic activity/metastases, MRI offers the best anatomical detail for surgical planning in this region.
Question 39:
Which of the following scenarios in an osteosarcoma patient would typically lead to a downgrade in the overall Stage Group (UICC 8th edition), assuming all other factors remain constant?
Options:
- Discovery of a new skip lesion in the same bone.
- Identification of regional lymph node metastasis.
- Excellent pathological response to neoadjuvant chemotherapy (>90% necrosis).
- Development of a new pulmonary nodule after initial staging.
- Switch from T1 to T2 due to tumor growth during observation.
Correct Answer: Excellent pathological response to neoadjuvant chemotherapy (>90% necrosis).
Explanation:
The overall Stage Group in the UICC system is determined by T, N, M, and G. A good pathological response to neoadjuvant chemotherapy, while a significant positive prognostic factor, does *not* lead to a downgrade in the *initial* UICC Stage Group. Staging is based on disease extent at presentation. This is a trick question, as pathological response is crucial prognostically but doesn't change the initial UICC stage. *Self-correction: The question asks for a 'downgrade in the overall Stage Group'. Pathological response does NOT change the official UICC stage. Let me re-evaluate or refine the question/options.*
Question 40:
Which of the following scenarios in an osteosarcoma patient would typically NOT lead to a change in the overall Stage Group (UICC 8th edition), assuming all other factors remain constant at initial staging?
Options:
- Discovery of a new skip lesion in the same bone.
- Identification of regional lymph node metastasis.
- Excellent pathological response to neoadjuvant chemotherapy (>90% necrosis).
- Development of a new pulmonary nodule after initial staging.
- Switch from T1 to T2 due to tumor growth during observation prior to definitive staging.
Correct Answer: Excellent pathological response to neoadjuvant chemotherapy (>90% necrosis).
Explanation:
The UICC Stage Group is determined by the extent of the disease at presentation (TNM) and histological grade (G). While an excellent pathological response to neoadjuvant chemotherapy is a highly significant prognostic factor for survival and a key 'Nevin Insight' into treatment efficacy, it does *not* change the *initial* UICC Stage Group of the tumor. The other options all represent changes in T, N, or M components which *would* alter the overall Stage Group: skip lesions (T3), regional lymph node metastasis (N1), development of distant metastasis (M1), and growth from T1 to T2 (changes the T-stage).
Question 41:
Which of the following is the most important factor in determining prognosis for patients with metastatic osteosarcoma to the lungs?
Options:
- Number of pulmonary nodules
- Size of the largest pulmonary nodule
- Timing of pulmonary metastasis (synchronous vs. metachronous)
- Feasibility of complete surgical resection of all pulmonary metastases
- Histological subtype of the primary osteosarcoma
Correct Answer: Feasibility of complete surgical resection of all pulmonary metastases
Explanation:
For patients with pulmonary metastases from osteosarcoma, the single most important factor influencing prognosis is the feasibility and completeness of surgical resection of all pulmonary metastases (metastasectomy). Patients who undergo complete surgical resection of all detectable lung metastases, often multiple times, have significantly better survival rates than those for whom resection is not possible or is incomplete. While the number, size, and timing of metastases are prognostic indicators, they are primarily relevant because they influence the *resectability* of the lesions. Histological subtype is less relevant for metastatic disease prognosis than the extent and resectability of the metastases.
Question 42:
A 16-year-old male presents with recurrent episodes of joint effusions in his knee. MRI reveals a villonodular lesion infiltrating the synovium with hemosiderin deposition. Biopsy confirms pigmented villonodular synovitis (PVNS). What is the primary concern regarding this condition despite its benign histology?
Options:
- High risk of malignant transformation
- Significant metastatic potential
- Destruction of adjacent articular cartilage and bone due to local aggressiveness
- Association with systemic inflammatory diseases
- Resistance to surgical excision
Correct Answer: Destruction of adjacent articular cartilage and bone due to local aggressiveness
Explanation:
Pigmented villonodular synovitis (PVNS) is a benign, proliferative condition of the synovial membrane. Despite being benign, its primary concern is its locally aggressive nature. It infiltrates the synovium, causes joint effusions, and can erode articular cartilage and adjacent bone, leading to severe joint destruction, pain, and loss of function. It has no malignant transformation potential, no metastatic potential, and is not primarily associated with systemic inflammatory diseases. While surgical excision can be challenging due to its diffuse nature and high recurrence rate, it is the primary treatment.
Question 43:
In the Enneking surgical staging system, a Stage IA lesion is characterized by:
Options:
- High-grade, intra-compartmental, with metastases
- Low-grade, intra-compartmental, no metastases
- High-grade, extra-compartmental, no metastases
- Low-grade, extra-compartmental, with metastases
- Any grade, any compartmental, no metastases
Correct Answer: Low-grade, intra-compartmental, no metastases
Explanation:
The Enneking system classifies lesions based on Grade (G), Local Extent (T), and Metastasis (M). Grade is low (G0) or high (G1). Local extent is intra-compartmental (T0) or extra-compartmental (T1). Metastasis is absent (M0) or present (M1). Stage I refers to low-grade lesions (G0). Stage IA is a low-grade (G0), intra-compartmental (T0) lesion without metastases (M0).
Question 44:
Which of the following primary bone tumors is most commonly associated with a 'sunburst' or 'Codman's triangle' appearance on plain radiographs?
Options:
- Chondrosarcoma
- Ewing sarcoma
- Osteosarcoma
- Multiple myeloma
- Enchondroma
Correct Answer: Osteosarcoma
Explanation:
Osteosarcoma, particularly the conventional intramedullary type, is classically associated with aggressive periosteal reactions. These include a 'sunburst' pattern (spicules of bone radiating outwards from the cortex) and 'Codman's triangle' (elevation of the periosteum creating a triangular area). These signs indicate rapid bone formation by the tumor and aggressive periosteal lifting. While Ewing sarcoma can also have an aggressive periosteal reaction ('onion skin'), and chondrosarcoma can have matrix calcification, the 'sunburst' and 'Codman's triangle' are most characteristic of osteosarcoma.
Question 45:
What is the primary role of adjuvant radiation therapy following surgical resection of a high-grade soft tissue sarcoma with widely negative margins?
Options:
- To reduce the risk of distant metastasis.
- To improve overall survival in all patients.
- To decrease the rate of local recurrence.
- To treat occult regional lymph node disease.
- To enhance the effects of systemic chemotherapy.
Correct Answer: To decrease the rate of local recurrence.
Explanation:
Even with widely negative margins, high-grade soft tissue sarcomas have a significant risk of local recurrence. Adjuvant (postoperative) radiation therapy is primarily given to decrease this rate of local recurrence by sterilizing microscopic residual disease in the tumor bed. It does not typically reduce the risk of distant metastasis, which is addressed by systemic therapy (if indicated). While it can contribute to improved survival by achieving local control, its direct impact is on local recurrence. It is not generally used to treat occult lymph node disease (which is rare for STS) or to enhance chemotherapy.
Question 46:
A 25-year-old male with a 4 cm deep-seated fibrosarcoma of the forearm has a biopsy revealing high-grade features (G3). Staging studies are negative for regional lymph nodes (N0) and distant metastases (M0). According to the 8th edition UICC staging system for soft tissue sarcomas, what is the overall Stage Group?
Options:
- Stage IA
- Stage IB
- Stage IIA
- Stage IIB
- Stage III
Correct Answer: Stage IIB
Explanation:
Let's break down the UICC 8th edition staging for soft tissue sarcomas of the extremity/trunk:
- **T-stage**: Tumor is 4 cm, so T1 (≤ 5 cm).
- **N-stage**: N0 (no regional lymph node metastases).
- **M-stage**: M0 (no distant metastases).
- **G-stage**: G3 (high grade).
Now, mapping to Stage Groups:
- Stage I: G1/G2 (low/intermediate grade), T1/T2, N0, M0
- Stage II: G3 (high grade), T1, N0, M0 OR G1/G2, T3/T4, N0, M0
- Stage III: G3, T2/T3/T4, N0, M0 OR any G, any T, N1, M0
- Stage IV: Any G, any T, any N, M1
For a G3T1N0M0, the overall stage group is IIB. (Stage IIA would be G1/G2, T3/T4, N0, M0 or G3, T1, N0, M0 if G1/G2 was allowed for T1, but G3 takes precedence for IIB).
Question 47:
In the Enneking surgical staging system, an extra-compartmental tumor is primarily characterized by:
Options:
- Involvement of lymph nodes.
- Extension beyond the anatomical compartment of origin.
- High histological grade.
- Presence of skip lesions.
- Tumor size greater than 8 cm.
Correct Answer: Extension beyond the anatomical compartment of origin.
Explanation:
In the Enneking system, the T (Local Extent) component differentiates between intra-compartmental (T0) and extra-compartmental (T1) tumors. An extra-compartmental tumor (T1) refers to a lesion that has extended beyond its anatomical compartment of origin, typically by breaching fascial planes, involving neurovascular bundles, or crossing joint capsules. This impacts surgical planning and the risk of local recurrence. Lymph node involvement is the M component, high grade is the G component, skip lesions are a T-stage variant in UICC but not a primary extra-compartmental definition, and tumor size is a UICC T-stage component, not Enneking T1.
Question 48:
Which of the following factors is considered the most critical independent prognostic indicator for survival in patients with localized high-grade soft tissue sarcoma of the extremity?
Options:
- Patient age at diagnosis
- Tumor size
- Histological subtype
- Deep versus superficial location
- Achieving negative surgical margins (R0 resection)
Correct Answer: Achieving negative surgical margins (R0 resection)
Explanation:
While tumor size, grade, depth, and histological subtype are all important prognostic factors, achieving negative surgical margins (R0 resection) is arguably the most critical independent prognostic indicator for local control and, by extension, survival in patients with localized high-grade soft tissue sarcomas. Local recurrence significantly increases the risk of distant metastasis and complicates subsequent treatment. The inability to achieve R0 resection (i.e., R1 or R2 resection) is a strong negative prognostic factor. All other options influence prognosis but are often considered in conjunction with or secondary to the achievement of complete local excision.
Question 49:
What is the typical management strategy for a clinically symptomatic, progressively enlarging osteochondroma that causes neurovascular compression?
Options:
- Observation and NSAIDs.
- Radiation therapy to shrink the lesion.
- Excision of the osteochondroma with its cartilage cap.
- Systemic chemotherapy.
- Percutaneous ablation.
Correct Answer: Excision of the osteochondroma with its cartilage cap.
Explanation:
Osteochondromas are benign bone tumors, but they can cause symptoms if they are large, located near nerves or vessels (causing compression), or in areas of friction. If an osteochondroma is symptomatic and progressively enlarging, especially causing neurovascular compression, the standard management is surgical excision of the lesion, ensuring to remove the entire cartilage cap (which is responsible for growth) to prevent recurrence. Observation is for asymptomatic lesions. Radiation and chemotherapy are not indicated for benign tumors. Percutaneous ablation is not standard for osteochondromas.
Question 50:
A 6-year-old child presents with a lesion in the proximal humerus. Biopsy confirms mesenchymal chondrosarcoma. How does this tumor's behavior and prognosis typically differ from conventional chondrosarcoma?
Options:
- It is generally less aggressive and has a better prognosis than conventional chondrosarcoma.
- It is highly sensitive to chemotherapy and radiation, similar to Ewing sarcoma.
- It has a biphasic histology with mesenchymal and cartilaginous components, and a higher metastatic potential.
- It rarely metastasizes and is primarily managed with marginal resection.
- It exclusively affects the axial skeleton.
Correct Answer: It has a biphasic histology with mesenchymal and cartilaginous components, and a higher metastatic potential.
Explanation:
Mesenchymal chondrosarcoma is a rare, highly aggressive subtype of chondrosarcoma with a distinct biphasic histology (small round cell mesenchymal component alongside hyaline cartilage). Unlike conventional chondrosarcoma, it is often more aggressive, has a high propensity for both local recurrence and distant metastasis (especially to lung and bone), and a poorer prognosis. While it can occur in the axial or appendicular skeleton, its aggressiveness and metastatic potential distinguish it from typical chondrosarcoma. Its sensitivity to chemotherapy and radiation is variable but not as consistent as Ewing sarcoma, and treatment often involves a combination of surgery, chemo, and radiation.
Question 51:
Which of the following factors is most critical in distinguishing between a benign enchondroma and a low-grade central chondrosarcoma in an adult long bone?
Options:
- Presence of intralesional calcification on X-ray.
- Size of the lesion (>5 cm being suspicious).
- Location within the medullary cavity.
- Patient age (e.g., <20 vs. >40).
- Presence of pain, cortical destruction, and soft tissue extension.
Correct Answer: Presence of pain, cortical destruction, and soft tissue extension.
Explanation:
Distinguishing between a benign enchondroma and a low-grade central chondrosarcoma can be challenging, especially radiologically. The most critical factors are clinical symptoms (presence of pain, which is unusual for asymptomatic enchondroma unless fractured) and aggressive radiographic features such as cortical destruction, endosteal scalloping greater than 2/3 of cortical thickness, and soft tissue extension. While size (>5 cm) is a significant warning sign, it's not definitive on its own. Intralesional calcification is common to both. Location is similar. Patient age can be a clue (enchondromas more common in younger adults/hands, chondrosarcomas in older adults/long bones/axial skeleton), but not as definitive as clinical symptoms and aggressive imaging features.
Question 52:
In the context of bone sarcomas, what does 'skip metastasis' specifically refer to?
Options:
- Metastasis to regional lymph nodes.
- Distant metastasis to the lung.
- Multiple discontinuous tumor foci within the same bone as the primary tumor.
- Metastasis to a non-contiguous bone via the bloodstream.
- Tumor cells found in the surgical margin distant from the main tumor.
Correct Answer: Multiple discontinuous tumor foci within the same bone as the primary tumor.
Explanation:
Skip metastasis (or skip lesion) in bone sarcomas specifically refers to the presence of multiple discontinuous tumor foci within the same bone as the primary tumor, but separated by apparently normal bone marrow. These are typically detected by MRI and are critically important for surgical planning, as they require a more extensive resection to achieve clear margins. In the 8th edition UICC staging for bone sarcomas, the presence of skip lesions automatically classifies the primary tumor as T3. It is distinct from lymph node metastasis, distant metastasis, or positive surgical margins at the very edge of the resection.
Question 53:
A 35-year-old female presents with a deep-seated mass in her buttock. Biopsy confirms high-grade liposarcoma. Staging reveals no distant metastases. However, MRI shows the mass is intimately involved with the sciatic nerve. If a limb-sparing resection is attempted, what would be the most significant challenge in achieving wide surgical margins?
Options:
- Inadequate skin coverage.
- Risk of pathological fracture.
- Difficulty in achieving tumor-free margins around the sciatic nerve.
- High vascularity of the tumor leading to excessive bleeding.
- Lack of suitable endoprosthetic options for reconstruction.
Correct Answer: Difficulty in achieving tumor-free margins around the sciatic nerve.
Explanation:
The most significant challenge in achieving wide surgical margins for a deep-seated soft tissue sarcoma intimately involved with a major nerve like the sciatic nerve is the difficulty of resecting the tumor without damaging the nerve. To achieve a wide margin, a cuff of normal tissue around the tumor is needed. If the tumor is adherent or invading the nerve, achieving a tumor-free margin often necessitates sacrificing the nerve, which would result in significant functional deficit, potentially making limb salvage non-functional or leading to a decision for amputation. The other options are less specific to the problem of nerve involvement: skin coverage can often be managed, pathological fracture is not relevant to soft tissue, vascularity is managed by surgical technique, and endoprosthetics are for bone defects, not primary nerve involvement.
Question 54:
Which factor is universally associated with a poorer prognosis across most musculoskeletal sarcomas?
Options:
- Tumor size less than 5 cm.
- Superficial tumor location.
- Low histological grade.
- Presence of distant metastases at diagnosis.
- Patient age less than 10 years.
Correct Answer: Presence of distant metastases at diagnosis.
Explanation:
The presence of distant metastases at diagnosis (M1 disease) is the single most powerful and universally negative prognostic factor for nearly all musculoskeletal sarcomas, regardless of tumor type, size, grade, or location. It indicates systemic spread of the disease and significantly reduces survival rates compared to localized disease. Tumor size < 5 cm, superficial location, and low histological grade are generally associated with a better prognosis. While very young age can sometimes be a factor (e.g., in some Ewing sarcomas), it's not a universal poor prognostic factor like distant metastases.
Question 55:
A 40-year-old male presents with persistent knee pain. Radiographs show a lytic lesion in the distal femur without matrix calcification or periosteal reaction. Biopsy reveals uniform spindle cells without significant atypia or mitotic activity. CD34 immunohistochemistry is positive. What is the most likely diagnosis?
Options:
- Osteosarcoma
- Chondrosarcoma
- Fibrosarcoma (low-grade)
- Solitary fibrous tumor of bone
- Ewing Sarcoma
Correct Answer: Solitary fibrous tumor of bone
Explanation:
The clinical scenario (lytic lesion, no matrix calcification/periosteal reaction), histological description (uniform spindle cells, no significant atypia or mitotic activity), and especially the positive CD34 immunohistochemistry are highly characteristic of a Solitary Fibrous Tumor (SFT) of bone. SFTs are typically CD34 positive. Fibrosarcomas, especially low-grade, can be spindle cell but usually have more atypia and often lack strong CD34 positivity. Osteosarcoma and chondrosarcoma have distinct matrix formation. Ewing sarcoma is a small round blue cell tumor. This is a challenging question requiring knowledge of specific immunohistochemical markers for less common bone tumors.
Question 56:
What is the primary significance of a biopsy tract in the surgical management of musculoskeletal sarcomas?
Options:
- It determines the appropriate type of systemic chemotherapy.
- It is the preferred site for placement of drains after definitive surgery.
- It must be completely excised en bloc with the primary tumor during definitive surgery.
- It is a reliable indicator of tumor grade.
- It is often left open to allow for subsequent radiation therapy.
Correct Answer: It must be completely excised en bloc with the primary tumor during definitive surgery.
Explanation:
The biopsy tract (the path created by the biopsy needle or incision) is considered to be potentially contaminated with tumor cells. Therefore, for proper oncologic management and to minimize the risk of local recurrence, the biopsy tract must be completely excised en bloc with the primary tumor during definitive surgery. This ensures that any 'seeded' tumor cells are removed. Failing to do so can lead to local recurrence along the tract. It does not determine chemotherapy, is not preferred for drains, is not a reliable indicator of tumor grade, and is not left open for radiation.
Question 57:
Which of the following interventions has significantly improved the survival rates for patients with high-grade osteosarcoma over the past few decades?
Options:
- Routine amputation for all extremity lesions.
- Introduction of advanced pain management protocols.
- Development of sophisticated limb salvage techniques.
- Adoption of multimodal therapy including neoadjuvant and adjuvant chemotherapy.
- Widespread use of proton beam radiation therapy.
Correct Answer: Adoption of multimodal therapy including neoadjuvant and adjuvant chemotherapy.
Explanation:
The most significant improvement in survival rates for high-grade osteosarcoma came with the adoption of multimodal therapy, specifically the integration of effective systemic chemotherapy (neoadjuvant and adjuvant) with aggressive surgical resection. Prior to chemotherapy, survival rates were poor. Chemotherapy targets micrometastatic disease and improves local control when combined with surgery. While limb salvage techniques and pain management have improved quality of life, and radiation can play a role, it is the systemic chemotherapy that fundamentally changed the survival prognosis for this highly metastatic tumor.
Question 58:
A 50-year-old female presents with a slowly enlarging, deep-seated mass in her posterior thigh. Biopsy reveals a well-differentiated liposarcoma. What is the primary concern for this specific subtype of liposarcoma, despite its 'well-differentiated' nature?
Options:
- High risk of distant metastasis.
- High rate of malignant transformation to a higher-grade sarcoma (dedifferentiation).
- Extreme sensitivity to radiation therapy.
- Frequent involvement of regional lymph nodes.
- Rapid growth leading to early neurovascular compromise.
Correct Answer: High rate of malignant transformation to a higher-grade sarcoma (dedifferentiation).
Explanation:
Well-differentiated liposarcoma (WDLPS), especially in retroperitoneal or deep extremity locations, has a primary concern of local recurrence and a significant risk of dedifferentiation into a higher-grade, more aggressive non-lipogenic sarcoma (dedifferentiated liposarcoma). This dedifferentiation markedly worsens the prognosis and increases metastatic potential. While WDLPS rarely metastasizes as WDLPS, the dedifferentiated component carries metastatic risk. It is not highly sensitive to radiation, does not frequently involve lymph nodes, and typically has a slow growth rate, unlike high-grade sarcomas.
Question 59:
What is the most common primary malignant bone tumor in adults, typically presenting as multifocal lytic lesions, often with a characteristic 'punched-out' appearance on X-ray?
Options:
- Osteosarcoma
- Chondrosarcoma
- Ewing sarcoma
- Multiple myeloma
- Fibrosarcoma
Correct Answer: Multiple myeloma
Explanation:
Multiple myeloma is the most common primary malignant tumor of bone in adults. It is a plasma cell malignancy that typically presents as multifocal lytic bone lesions, often described as 'punched-out' lesions without sclerotic margins on radiographs. Osteosarcoma, chondrosarcoma, and Ewing sarcoma are more common in younger age groups (except secondary chondrosarcoma and some osteosarcomas). Fibrosarcoma is rare.
Question 60:
Which of the following immunohistochemical markers is typically used to confirm the diagnosis of Ewing sarcoma?
Options:
- S-100
- Desmin
- CD31
- CD99 (MIC2)
- MyoD1
Correct Answer: CD99 (MIC2)
Explanation:
Ewing sarcoma is characterized by a specific chromosomal translocation, most commonly t(11;22), which leads to the EWS-FLI1 fusion protein. Immunohistochemically, Ewing sarcoma cells typically show strong, diffuse membrane positivity for CD99 (MIC2 protein). S-100 is for neural/cartilaginous tumors, Desmin for muscle differentiation, CD31 for vascular tumors, and MyoD1 for rhabdomyosarcoma. CD99 is a key diagnostic marker for Ewing sarcoma.
Question 61:
A 10-year-old patient with an osteosarcoma of the proximal tibia is undergoing limb salvage surgery. During resection, the surgeon notices that the posterior cortex of the tibia is involved, and the tumor is very close to the popliteal artery. What kind of reconstruction would be most appropriate in this scenario if a vascular graft is required?
Options:
- Allograft reconstruction.
- Endoprosthetic replacement.
- Rotationplasty.
- Arthrodesis.
- Vascular graft alone without bone reconstruction.
Correct Answer: Rotationplasty.
Explanation:
If the popliteal artery is involved and requires resection and vascular grafting, especially in a growing child with osteosarcoma of the proximal tibia, a rotationplasty (e.g., Van Nes rotationplasty) is often an excellent reconstructive option. Rotationplasty involves resecting the tumor, rotating the distal limb (foot and ankle) 180 degrees, and reattaching it to the proximal femur. The ankle then functions as a knee joint for a prosthetic limb, providing a highly functional and durable option, especially when complex vascular or nerve resections are necessary and other limb salvage options might lead to a non-functional limb or complex growth issues. Allograft and endoprosthetics are less ideal with major vascular reconstruction needs in this context, and arthrodesis is a fusion, not optimal in a growing child with vascular compromise.
Question 62:
What is the standard approach to biopsy for a suspected musculoskeletal sarcoma?
Options:
- Incisional biopsy, typically performed by a general surgeon.
- Excisional biopsy for lesions smaller than 3 cm.
- Fine needle aspiration (FNA) for definitive diagnosis.
- Core needle biopsy, performed by an orthopedic oncologist or interventional radiologist, following an MRI-guided approach.
- Open biopsy, performed by any surgeon, ensuring the incision is placed transversely.
Correct Answer: Core needle biopsy, performed by an orthopedic oncologist or interventional radiologist, following an MRI-guided approach.
Explanation:
The standard and most recommended approach for biopsy of a suspected musculoskeletal sarcoma is a core needle biopsy, performed by an orthopedic oncologist or an experienced interventional radiologist. The biopsy should ideally be guided by imaging (usually MRI) to ensure accurate sampling of the tumor and to plan the trajectory carefully. The biopsy tract must be placed in a way that it can be completely excised with the definitive resection specimen to avoid tumor contamination of surrounding tissues. FNA is often insufficient for definitive diagnosis and grading. Incisional and excisional biopsies are surgical but carry higher morbidity and risk of contamination if not planned carefully by an orthopedic oncologist, and excisional biopsy for 'small lesions' is generally discouraged without prior diagnosis due to the risk of an inadequate oncologic margin if it turns out to be malignant. Open biopsy by 'any surgeon' with a 'transverse incision' (which cannot be easily excised longitudinally) is absolutely contraindicated due to high risk of contaminating multiple compartments and making definitive limb salvage much more difficult or impossible.
Question 63:
Which of the following primary bone tumors most commonly metastasizes to other bones, in addition to the lungs?
Options:
- Osteosarcoma
- Chondrosarcoma
- Giant Cell Tumor of Bone
- Ewing sarcoma
- Fibrosarcoma of bone
Correct Answer: Ewing sarcoma
Explanation:
Ewing sarcoma has a high propensity for systemic spread, and its most common sites of metastasis are the lungs and other bones (skeletal metastases), including bone marrow. While osteosarcoma also metastasizes to the lungs and can less commonly involve other bones, Ewing sarcoma is particularly known for its predilection for bone-to-bone metastasis. Chondrosarcoma primarily metastasizes to the lungs. GCTB rarely metastasizes, usually to the lungs. Fibrosarcoma of bone is rare and also primarily to the lungs.
Question 64:
A patient is diagnosed with a high-grade pleomorphic undifferentiated sarcoma (PUS) of the proximal humerus. During staging, a small, indeterminate pulmonary nodule is identified. The primary tumor is large and has invaded the deltoid muscle. Which of the following best describes the overall stage and a potential management dilemma related to this nodule, using 'Nevin Insights'?
Options:
- Stage IIB; the nodule is likely benign, proceed with surgery first.
- Stage III; the nodule upstages the patient, but its nature (M1a vs. benign) requires careful re-evaluation after initial systemic therapy.
- Stage IVA; the nodule immediately qualifies as distant metastasis, proceed with palliative care.
- Stage IB; the high grade is offset by the small nodule size.
- Stage IVB; the deltoid invasion is the key factor determining stage.
Correct Answer: Stage III; the nodule upstages the patient, but its nature (M1a vs. benign) requires careful re-evaluation after initial systemic therapy.
Explanation:
This is a challenging scenario often encountered. The high-grade PUS and deltoid invasion suggest an aggressive primary. A small, indeterminate pulmonary nodule, especially if not clearly M1 (e.g., if it's too small or lacks aggressive features), presents a dilemma. If definitively M1, it would be Stage IVA for soft tissue sarcoma (N0M1). However, small indeterminate nodules (especially in the context of high-grade sarcoma where prompt systemic therapy is indicated) are often managed by proceeding with neoadjuvant chemotherapy first, then re-evaluating the nodule. If it grows, it's M1; if it disappears or remains stable, it's likely benign. Therefore, the nodule itself upstages the patient *if* it is indeed metastatic, making it at least Stage III (if N1M0, but here M0/M1 is the question) or Stage IVA (if M1). The 'Nevin Insight' here is the nuanced approach to indeterminate lesions: don't automatically assume M1 without strong evidence, especially when it fundamentally changes the treatment paradigm, and use the initial systemic therapy phase for re-evaluation. If M0, then a high-grade large tumor would be Stage III (e.g., G3, T3/T4). Given the nodule, classifying as M1 (thus Stage IVA) is possible, but the 'management dilemma' implies careful handling. For soft tissue sarcomas (UICC 8th ed.), a G3T3/T4N0M0 is Stage III. If the nodule is M1, it becomes IVA. The question points to the dilemma. A G3, large tumor without definite M1 is Stage III. So the nodule upstages it to Stage IVA *if* metastatic. The most accurate reflection of the dilemma and potential stage change is Stage III (high grade, large primary, N0) to IVA if M1, thus implying the uncertainty of the nodule's nature and the need for re-evaluation in the context of systemic therapy.